137 related articles for article (PubMed ID: 1649762)
1. [3H]ramiprilat binding to the angiotensin-converting enzyme in rat renal brush-border membranes: the effect of chloride.
Grima M; Mosser J; Welsch C; Barthelmebs M; Imbs JL
Eur J Pharmacol; 1991 Mar; 206(3):203-9. PubMed ID: 1649762
[TBL] [Abstract][Full Text] [Related]
2. High affinity binding of ramiprilat on isolated human glomeruli.
Albus U; Kress I; Linz W; Vasmant D; Delarue F; Sraer JD
Biochem Pharmacol; 1988 Dec; 37(24):4679-84. PubMed ID: 2849453
[TBL] [Abstract][Full Text] [Related]
3. High-affinity binding of the converting enzyme inhibitor, ramiprilat, to isolated human glomeruli.
Becker RH; Albus U; Kress I; Linz W; Vasmant D; Delarue F; Sraer JD
J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S31-4. PubMed ID: 2474098
[TBL] [Abstract][Full Text] [Related]
4. Effects of one-hour and one-week treatment with ramipril on plasma and renal brush border angiotensin converting enzyme in the rat.
Michel B; Stephan D; Grima M; Barthelmebs M; Imbs JL
Eur J Pharmacol; 1993 Oct; 242(3):237-43. PubMed ID: 8281988
[TBL] [Abstract][Full Text] [Related]
5. In vitro interactions between ramiprilat and angiotensin I-converting enzyme in endothelial cells.
Baudin B; Drouet L
J Cardiovasc Pharmacol; 1989; 14 Suppl 4():S37-42. PubMed ID: 2483427
[TBL] [Abstract][Full Text] [Related]
6. Effect of temperature and chloride on steady-state inhibition of angiotensin I-converting enzyme by enalaprilat and ramiprilat.
Skoglof A; Göthe PO; Deinum J
Biochem J; 1990 Dec; 272(2):415-9. PubMed ID: 2176463
[TBL] [Abstract][Full Text] [Related]
7. In vitro tissue potencies of converting enzyme inhibitors. Prodrug activation by kidney esterase.
Grima M; Welsch C; Michel B; Barthelmebs M; Imbs JL
Hypertension; 1991 Apr; 17(4):492-6. PubMed ID: 2013476
[TBL] [Abstract][Full Text] [Related]
8. Effects of dietary protein and uninephrectomy on renal angiotensin converting enzyme activity in the rat.
Michel B; Grima M; Coquard C; Welsch C; Barthelmebs M; Imbs JL
Kidney Int; 1994 Jun; 45(6):1587-92. PubMed ID: 7933806
[TBL] [Abstract][Full Text] [Related]
9. Kinetic properties of the angiotensin converting enzyme inhibitor ramiprilat.
Bünning P
J Cardiovasc Pharmacol; 1987; 10 Suppl 7():S31-5. PubMed ID: 2485060
[TBL] [Abstract][Full Text] [Related]
10. Human physiologically based pharmacokinetic model for ACE inhibitors: ramipril and ramiprilat.
Levitt DG; Schoemaker RC
BMC Clin Pharmacol; 2006 Jan; 6():1. PubMed ID: 16398929
[TBL] [Abstract][Full Text] [Related]
11. Assay of tissue angiotensin converting enzyme.
Welsch C; Grima M; Giesen EM; Helwig JJ; Barthelmebs M; Coquard C; Imbs JL
J Cardiovasc Pharmacol; 1989; 14 Suppl 4():S26-31. PubMed ID: 2483425
[TBL] [Abstract][Full Text] [Related]
12. Effect of angiotensin converting enzyme inhibitors on the vasoconstrictor action of angiotensin I on isolated rat kidney.
Schmidt M; Giesen-Crouse EM; Krieger JP; Welsch C; Imbs JL
J Cardiovasc Pharmacol; 1986; 8 Suppl 10():S100-5. PubMed ID: 2438482
[TBL] [Abstract][Full Text] [Related]
13. [Changing factors of the activity of angiotensin converting enzyme of renal brush border in rats].
Michel B; Grima M; Welsch C; Coquard C; Barthelmebs M; Imbs JL
Arch Mal Coeur Vaiss; 1991 Aug; 84(8):1201-4. PubMed ID: 1659346
[TBL] [Abstract][Full Text] [Related]
14. Effect of inhibitors on the coordination geometries of cadmium at the metal sites in angiotensin-I-converting enzyme.
Carvalho E; Göthe PO; Bauer R; Danielsen E; Hemmingsen L
Eur J Biochem; 1995 Dec; 234(3):780-5. PubMed ID: 8575435
[TBL] [Abstract][Full Text] [Related]
15. Characterization of angiotensin converting enzyme by [3H]captopril binding.
Strittmatter SM; Snyder SH
Mol Pharmacol; 1986 Feb; 29(2):142-8. PubMed ID: 3005826
[TBL] [Abstract][Full Text] [Related]
16. [Ramipril and cardiac and renal angiotensin converting enzyme].
Grima M; Stephan D; Welsch C; Coquard C; Barthelmebs M; Imbs JL
Arch Mal Coeur Vaiss; 1995 Feb; 88 Spec No 2():43-8. PubMed ID: 7646311
[TBL] [Abstract][Full Text] [Related]
17. Effects of triiodothyronine and dexamethasone on plasma and tissue angiotensin converting enzyme in the rat.
Michel B; Grima M; Coquard C; Welsch C; Barthelmebs M; Imbs JL
Fundam Clin Pharmacol; 1994; 8(4):366-72. PubMed ID: 7851842
[TBL] [Abstract][Full Text] [Related]
18. The two homologous domains of human angiotensin I-converting enzyme interact differently with competitive inhibitors.
Wei L; Clauser E; Alhenc-Gelas F; Corvol P
J Biol Chem; 1992 Jul; 267(19):13398-405. PubMed ID: 1320019
[TBL] [Abstract][Full Text] [Related]
19. Evidence for two binding sites on membrane-bound angiotensin-converting enzymes (ACE) for exogenous inhibitors except in testis.
Brée F; Hamon G; Tillement JP
Life Sci; 1992; 51(10):787-94. PubMed ID: 1325020
[TBL] [Abstract][Full Text] [Related]
20. Mixed-type inhibition of pulmonary angiotensin I-converting enzyme by captopril, enalaprilat and ramiprilat.
Baudin B; Bénéteau-Burnat B
J Enzyme Inhib; 1999; 14(6):447-56. PubMed ID: 10536878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
